SPDR S&P Biotech ETF Options Spot-On: On January 27th, 94,927 Contracts Were Traded, With 642.97K Open Interest

On January 27th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 94,927 options for the day, of which put options accounted for 61.87% of the total

Futu News05:30

SPDR S&P Biotech ETF Options Spot-On: On January 23rd, 81,137 Contracts Were Traded, With 588.64K Open Interest

On January 23rd ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 81,137 options for the day, of which put options accounted for 65.5% of the total

Futu NewsJan 24 05:30

'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds

BenzingaJan 17 23:35

SPDR S&P Biotech ETF Options Spot-On: On January 14th, 92,360 Contracts Were Traded, With 927.64K Open Interest

On January 14th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 92,360 options for the day, of which put options accounted for 69.71% of the total

Futu NewsJan 15 05:30

On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?

In 2025, the Biomedical mergers and acquisitions will begin.

wallstreetcnJan 14 19:01

SPDR S&P Biotech ETF Options Spot-On: On January 13th, 93,959 Contracts Were Traded, With 948.11K Open Interest

On January 13th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 93,959 options for the day, of which put options accounted for 61.69% of the total

Futu NewsJan 14 05:30